Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Oral Semaglutide

OASIS 2

Novo Nordisk · Phase 3 · Completed · Enrollment 201

NCT05132088

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
oral semaglutide 50 mg once daily34 participants20 participants22 participantsn/r0
oral semaglutide placebo once daily5 participants2 participants6 participantsn/r0

A count stays a count. This page does not turn a count into a percent.